Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2026 08:47 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24,...
July 23, 2026 07:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform

Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications ...
July 15, 2026 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --...
July 13, 2026 21:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
July 13, 2026 07:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

IP portfolio reflects Autonomix’s neural sensing leadership in multi-billion-dollar denervation market Technical highlights on newly issued patent include real-time nerve monitoring and diagnostic...
June 22, 2026 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

Platform Expected to Target Expansion into Multi-Billion-Dollar Cardiovascular Market with Potential Class II Diagnostic Regulatory Path Architecture Supports Future Expansion into Denervation,...
June 18, 2026 16:30 ET | Source: Autonomix Medical, Inc.

Autonomix Announces Reverse Stock Split

THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
June 10, 2026 09:05 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing...
June 04, 2026 09:05 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform Potential Access the segment here THE...
May 19, 2026 08:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall Patent strengthens intellectual property foundation for next-generation...